ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.86−0.44 (-5.30%)
Close on Nov 17, 2026Market cap $251.95MP/E –Yield –
ClearPoint Neuro price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
ClearPoint Neuro's price to book ratio was 26.0× on Nov 11, 2026, against 25.9× a year earlier. Over the last 5 years it ranged from 4.2× to 42.9×, with a median of 7.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 26.0× | +1.5 |
| 2025 | Dec 31, 2025 | 24.5× | +9.9 |
| 2024 | Dec 31, 2024 | 14.6× | +7.7 |
| 2023 | Dec 29, 2023 | 6.9× | +1.7 |
| 2022 | Dec 30, 2022 | 5.2× | −0.6 |
| 2021 | Dec 31, 2021 | 5.8× | −75.3 |
| 2020 | Oct 30, 2020 | 81.1× | +69.1 |
| 2019 | Dec 31, 2019 | 12.0× | +5.0 |
| 2018 | Dec 31, 2018 | 6.9× | +3.0 |
| 2017 | Dec 29, 2017 | 3.9× | −17.5 |
| 2016 | Dec 30, 2016 | 21.4× | – |
See a number that looks wrong?